A federal judge has cleared the way for Zantac cancer lawsuits to proceed after rejecting an effort by defendants to have all the claims against them dismissed.…
A federal judge has ruled in favor of GlaxoSmithKline, saying Zofran birth defect lawsuits are preempted by federal law due to the FDA’s refusal to update the label warnings.…
A federal judge is prepared to hear arguments over whether Zantac lawsuits filed over NDMA contamination and cancer claims can move forward on June 3 and 4.…
Plaintiffs say Zantac manufacturers have destroyed evidence and intentionally delayed the discovery process for ongoing federal litigation in violation of court orders.…
GlaxoSmithKline has sold a plant in India once used to make the recalled heartburn drug Zantac for only a fraction of its initial cost.…
After a number of delays, the first Zofran birth defects bellwether trial is expected to begin in October 2021.…
The makers of Zofran argue that a recent FDA rejection of calls to investigate old data on whether it causes birth defects gives the company protection from hundreds of lawsuits.…
A new study links NDMA found in Zantac to a higher risk of gastrointestinal cancers than other heartburn drugs.…
A new study reports to have found how Zantac changes into NDMA, which has been linked to an increased risk of cancer.…
A Zantac lawsuit claims the recalled heartburn drug gave a man bladder cancer which required multiple surgeries and continuous medical monitoring.…
